What is ALS Phase 3 Study Ceftriaxone?

Category: Others

false

See also: Clinical Trial

NCT00349622 is a clinical trial with ceftriaxone in subjects with amyotrophic lateral sclerosis (ALS). Other study IDs include: U01NS049640-02, NINDS, U01NS049640-02, NINDS CRC.

Reported purpose & perceived effectiveness


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects of ALS Phase 3 Study Ceftriaxone

Severe
2
Moderate
4
Mild
3
None
7

Commonly reported side effects, conditions, and hospitalizations associated with ALS Phase 3 Study Ceftriaxone

Patients
3
Patients
1
Patients
1
Patients
1

Show all 15 reported side effects

Dosages

Most common dosages (by patients currently using ALS Phase 3 Study Ceftriaxone)
Dosage
4 g daily
Patients
5
Dosage
2 other daily
Patients
2
Dosage
1 other daily
Patients
1
Dosage
2 mg daily
Patients
1
Dosage
50 mg daily
Patients
1
Why Patients Stopped Using ALS Phase 3 Study Ceftriaxone (multiple reasons could be selected)
Reason
Side effects too severe
Patients
4
Reason
Course of treatment ended
Patients
4
Reason
Doctor's advice
Patients
3
Reason
Other
Patients
2
Reason
Did not seem to work
Patients
1
See all 11 patients who’ve stopped using ALS Phase 3 Study Ceftriaxone

Duration

Currently Using ALS Phase 3 Study Ceftriaxone
Duration
Patients
Duration
0-1 month
Patients
0
Duration
1-3 months
Patients
0
Duration
3-6 months
Patients
0
Duration
6 months-1 year
Patients
0
Duration
1-2 years
Patients
0
Duration
2 years or more
Patients
1
Stopped Using ALS Phase 3 Study Ceftriaxone
Duration
Patients
Duration
0-1 month
Patients
2
Duration
1-3 months
Patients
0
Duration
3-6 months
Patients
0
Duration
6 months-1 year
Patients
2
Duration
1-2 years
Patients
6
Duration
2 years or more
Patients
1

Adherence


Always
Patients
13
81%
Usually
Patients
1
6%
Sometimes
Patients
0
0%
Never taken as prescribed
Patients
2
13%

Burden


Very hard to take
Patients
3
19%
Somewhat hard to take
Patients
8
50%
A little hard to take
Patients
4
25%
Not at all hard to take
Patients
1
6%

Cost per month


Cost per month
$200+
Patients
1
6%
Cost per month
$100-199
Patients
0
0%
Cost per month
$50-99
Patients
0
0%
Cost per month
$25-49
Patients
0
0%
Cost per month
< $25
Patients
12
75%
Cost per month
Not specified
Patients
3
19%
Last updated:

2 patient evaluations for ALS Phase 3 Study Ceftriaxone

7573
Portrait default thumb
7573
Sex: F
Data Quality: 1 star
Bulbar: mild
Arms: mild
Chest: mild
Legs: moderate
I am: g
I have:
ALS

See 7573's full ALS Phase 3 Study Ceftriaxone history

Apr 29, 2011 (Started Oct 22, 2010)

  • Effectiveness
    Can’t tell (for ALS (Amyotrophic Lateral Sclerosis))
  • Side Effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 1 other Daily
Advice & Tips: I take this treatment twice a day. People tell me that my ALS is moving slower.
Cost: < $25 monthly

Mar 4, 2011 (Started Oct 22, 2010)

  • Effectiveness
    Can’t tell (for ALS (Amyotrophic Lateral Sclerosis))
  • Side Effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 1 other Daily
Advice & Tips: I think this is a good study. We set a time each morning to take the medication, and it is no problem for us. I feel I swallow better when I am on the medication. Taking this medication is an adjustment to my life, but so is ALS and if this is going help me, I'll do it.
Cost: < $25 monthly

  • 0 helpful marks
moolaw
27024 thumb
moolaw
Sex: F
Data Quality: 0 stars
Bulbar: moderate
Arms: severe
Chest: moderate
Legs: severe
I am: b
I have:
ALS

See moolaw's full ALS Phase 3 Study Ceftriaxone history

Dec 20, 2010 (Started Oct 11, 2010)

  • Effectiveness
    Can’t tell (for Participate in clinical trial)
  • Side Effects
    Mild (Lymphocytopenia (low lymphocytes), Itching and rash from patch adhesive)
  • Adherence
    Usually
  • Burden
    Somewhat hard to take
Dosage: 2 mg Daily
Advice & Tips: It's no problem for me, but my husband has so much to do that he forgets to thaw the medicine sometimes.
Cost: < $25 monthly
Side effects: Lymphocytopenia (low lymphocytes), Itching and rash from patch adhesive

Nov 20, 2010 (Started Oct 11, 2010)

  • Effectiveness
    None (for Participate in clinical trial)
  • Side Effects
    Moderate (Lymphocytopenia (low lymphocytes), Itching and rash from patch adhesive)
  • Adherence
    Usually
  • Burden
    Somewhat hard to take
Dosage: 2 mg Daily
Advice & Tips: I feel like I'm getting worse more quickly, but don't know whether it is the study drug or riluzole.
Cost: < $25 monthly
Side effects: Lymphocytopenia (low lymphocytes), Itching and rash from patch adhesive

Oct 21, 2010 (Started Oct 11, 2010)

  • Effectiveness
    Can’t tell (for Participate in clinical trial)
  • Side Effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 4 g Daily
Advice & Tips: I was afraid that the procedures for administering the drug would be difficult, but it isn't too hard for my husband to do and it is easy to schedule early in the morning and then before bed. I feel good about participating in a trial.
Cost: < $25 monthly
Side effects: Lymphocytopenia (low lymphocytes), Itching and rash from patch adhesive

  • 0 helpful marks
Last updated:
Showing 2 of 2 patient evaluations for ALS Phase 3 Study Ceftriaxone